Sequential electrocoagulation and resection for carcinoma of the rectum

Area of Science:

• Oncology
• Surgical Oncology
• Gastrointestinal Surgery

Background:

• Rectal cancer treatment traditionally involves surgery, radiation, and chemotherapy.
• Local recurrence remains a significant challenge in rectal cancer management.
• Previous surgical techniques have limitations in achieving complete tumor removal and preserving function.

Purpose of the Study:

• To evaluate the efficacy of sequential electrocoagulation followed by surgical resection for rectal carcinoma.
• To assess the impact of this combined modality on patient survival rates and local recurrence.
• To determine the safety and feasibility of preoperative electrocoagulation in rectal cancer treatment.

Main Methods:

• A cohort of over 200 patients with rectal carcinoma underwent sequential electrocoagulation followed by surgical resection.
• Treatment involved preoperative electrocoagulation, typically 3-5 days prior to resection.
• Surgical options included low anterior resection or abdominoperineal resection based on lesion characteristics.

Main Results:

• The overall five-year survival rate for the combined approach was 67%.
• Sequential electrocoagulation followed by low anterior resection yielded a five-year survival rate of 84.6% (55/65 patients).
• Local recurrence was significantly reduced, occurring in only 5% of patients.

Conclusions:

• Sequential electrocoagulation followed by resection is a safe and effective treatment for rectal carcinoma, offering improved survival.
• This combined modality can prevent local recurrence and potentially expand the applicability of sphincter-saving procedures.
• Electrocoagulation, radiation, and surgery are complementary treatments that can provide additive benefits in rectal cancer management.